SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Medeva PLC
An SI Board Since May 1998
Posts SubjectMarks Bans
9 1 0
Emcee:  Dayuhan Type:  Unmoderated
Introduction Compact
Came across this Co. while doing research on AVIR. They're a British manufacturer of drugs and vaccines, a fair range of products, pretty consistently profitable. They supply a flu vaccine to AVIR that seems to stand a good chance of FDA approval, which could be a major new earner. ADRs trade in NY at a little over $12, after steady decline. Common stock trades on London exchange. EPS is around $1.40, P/E is under 9.

Given the number of stocks in this price category with no earnings at all, or with astronomical losses, this would seem undervalued to me... or is there a skeleton in the closet that I'm not aware of?

Comments?

Steve Rogers
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News